News

Arialys Presents Two Abstracts at AAN 2025

February 26, 2025

Arialys Therapeutics Initiates MAD Cohorts Having Completed All Planned SAD Cohorts in a Phase 1 Study of ART5803 for the Treatment of Autoimmune Neuropsychiatric Disease

December 11, 2024

In Vivo Podcast: Treating Autoimmune Neuropsychiatric Diseases

December 10, 2024

Arialys Presents at ACNP Annual Meeting 2024

October 22, 2024

Arialys Therapeutics Appoints Sankalp Gokhale, M.D., Chief Medical Officer

October 10, 2024

Arialys Therapeutics Announces First Participants Dosed in a Phase 1 Clinical Trial of ART5803, a Precision Medicine for the Treatment of Autoimmune Neuropsychiatric Diseases